The role of estrogen receptor β and nicotinic cholinergic receptors in postpartum depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 40, Issue 1, 2013, Pages 199-206

  Fernandez, Jamie Winderbaum ^a   Grizzell, J Alex ^a   Wecker, Lynn ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Depression; Estrogen; Estrogen receptor ; Hypothalamic pituitary adrenal (HPA) axis; Nicotine

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; COUMESTROL; DESIPRAMINE; DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LETROZOLE; MECAMYLAMINE; NICOTINE DERIVATIVE; NICOTINIC RECEPTOR; TAMOXIFEN; VARENICLINE;

ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; DEPRESSION; DRUG EFFICACY; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PUERPERAL DEPRESSION; RELAPSE; REVIEW; SEX DIFFERENCE; SMOKING; TREATMENT RESPONSE;

BRAIN; DEPRESSION, POSTPARTUM; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; RECEPTORS, NICOTINIC;

EID: 84868230161     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.10.002     Document Type: Review

References (170)

1. Abraham I.M., Han S.K., Todman M.G., Korach K.S., Herbison A.E. Estrogen receptor β mediates rapid estrogen actions on gonadotropin-releasing hormone neurons in vivo. J Neurosci 2003, 23:5771-5777.
2. Abraham I.M., Koszegi Z., Tolod-Kemp E., Szego E.M. Action of estrogen on survival of basal forebrain cholinergic neurons: promoting amelioration. Psychoneuroendocrinology 2009, 34(Suppl. 1):S104-S112.
3. Allen A.M., Prince C.B., Dietz P.M. Postpartum depressive symptoms and smoking relapse. Am J Prev Med 2009, 36:9-12.
4. Alves S.E., Lopez V., McEwen B.S., Weiland N.G. Differential colocalization of estrogen receptor β (ERβ) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc Natl Acad Sci U S A 1998, 95:3281-3286.
5. Amantea D., Russo R., Bagetta G., Corasaniti M.T. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res 2005, 52:119-132.
6. Anderson G.L., Judd H.L., Kaunitz A.M., Barad D.H., Beresford S.A., Pettinger M., et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 2003, 290:1739-1748.
7. Arpels J.C. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. J Reprod Med 1996, 41:633-639.
8. Atchley D.P., Weaver K.L., Eckel L.A. Taste responses to dilute sucrose solutions are modulated by stage of the estrous cycle and fenfluramine treatment in female rats. Physiol Behav 2005, 86:265-271.
9. Atkinson L., Paglia A., Coolbear J., Niccols A., Parker K.C., Guger S. Attachment security: a meta-analysis of maternal mental health correlates. Clin Psychol Rev 2000, 20:1019-1040.
10. Aubin H.J., Rollema H., Svensson T.H., Winterer G. Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev 2012, 36:271-284.
11. Balfour D.J., Khullar A.K., Longden A. Effects of nicotine on plasma corticosterone and brain amines in stressed and unstressed rats. Pharmacol Biochem Behav 1975, 3:179-184.
12. Bardin A., Boulle N., Lazennec G., Vignon F., Pujol P. Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004, 11:537-551.
13. Beck C.T. Predictors of postpartum depression: an update. Nurs Res 2001, 50:275-285.
14. Beck C.T., Gable R.K. Comparative analysis of the performance of the Postpartum Depression Screening Scale with two other depression instruments. Nurs Res 2001, 50:242-250.
15. Bethea C.L., Gundlah C., Mirkes S.J. Ovarian steroid action in the serotonin neural system of macaques. Novartis Found Symp 2000, 230:112-130. [discussion 130-113].
16. Biegon A., Kim S.W., Logan J., Hooker J.M., Muench L., Fowler J.S. Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons. Biol Psychiatry 2010, 67:774-777.
17. Binder E.B., Nemeroff C.B. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry 2010, 15:574-588.
18. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005, 19:833-842.
19. Bloch M., Schmidt P.J., Danaceau M., Murphy J., Nieman L., Rubinow D.R. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000, 157:924-930.
20. Bodo C., Rissman E.F. New roles for estrogen receptor β in behavior and neuroendocrinology. Front Neuroendocrinol 2006, 27:217-232.
21. Born L., Shea A., Steiner M. The roots of depression in adolescent girls: is menarche the key?. Curr Psychiatry Rep 2002, 4:449-460.
22. Brandenberger A.W., Tee M.K., Jaffe R.B. Estrogen receptor alpha (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. J Clin Endocrinol Metab 1998, 83:1025-1028.
23. Breese McCoy S.J. Postpartum depression: an essential overview for the practitioner. South Med J 2011, 104:128-132.
24. Brunzell D.H., Russell D.S., Picciotto M.R. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J Neurochem 2003, 84:1431-1441.
25. Butler P.D., Weiss J.M., Stout J.C., Nemeroff C.B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 1990, 10:176-183.
26. Cam G.R., Bassett J.R. The effect of acute nicotine administration on plasma levels of the thyroid hormones and corticosterone in the rat. Pharmacol Biochem Behav 1983, 19:559-561.
27. Campbell-Thompson M., Lynch I.J., Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERβ isoforms in colon cancer. Cancer Res 2001, 61:632-640.
28. Carmichael S.L., Ahluwalia I.B. Correlates of postpartum smoking relapse. Results from the Pregnancy Risk Assessment Monitoring System (PRAMS). Am J Prev Med 2000, 19:193-196.
29. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 1986, 6:2908-2914.
30. Chen Y., Hatalski C.G., Brunson K.L., Baram T.Z. Rapid phosphorylation of the CRE binding protein precedes stress-induced activation of the corticotropin releasing hormone gene in medial parvocellular hypothalamic neurons of the immature rat. Brain Res Mol Brain Res 2001, 96:39-49.
31. Chen H., Fu Y., Sharp B.M. Chronic nicotine self-administration augments hypothalamic-pituitary-adrenal responses to mild acute stress. Neuropsychopharmacology 2008, 33:721-730.
32. Cizza G., Gold P.W., Chrousos G.P. High-dose transdermal estrogen, corticotropin-releasing hormone, and postnatal depression. J Clin Endocrinol Metab 1997, 82:704.
33. 125I]-alpha-bungarotoxin. J Neurosci 1985, 5:1307-1315.
34. Cramer D.W., Harlow B.L., Xu H., Fraer C., Barbieri R. Cross-sectional and case-controlled analyses of the association between smoking and early menopause. Maturitas 1995, 22:79-87.
35. Cuijpers P., Brannmark J.G., van Straten A. Psychological treatment of postpartum depression: a meta-analysis. J Clin Psychol 2008, 64:103-118.
36. Dani J.A., Harris R.A. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 2005, 8:1465-1470.
37. Dao T.T., LeResche L. Gender differences in pain. J Orofac Pain 2000, 14:169-184. [discussion 184-195].
38. Dickinson J.A., Kew J.N., Wonnacott S. Presynaptic α7- and β2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms. Mol Pharmacol 2008, 74:348-359.
39. Donner N., Handa R.J. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009, 163:705-718.
40. Fan X., Xu H., Warner M., Gustafsson J.A. ERbeta in CNS: new roles in development and function. Prog Brain Res 2010, 181:233-250.
41. Faraday M.M., Blakeman K.H., Grunberg N.E. Strain and sex alter effects of stress and nicotine on feeding, body weight, and HPA axis hormones. Pharmacol Biochem Behav 2005, 80:577-589.
42. Flandreau E.I., Ressler K.J., Owens M.J., Nemeroff C.B. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 2012, 37:27-38.
43. Gallicchio L., Macdonald R., Wood B., Rushovich E., Helzlsouer K.J. Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy. Climacteric 2012, 15:339-349.
44. Gentile N.E., Andrekanic J.D., Karwoski T.E., Czambel R.K., Rubin R.T., Rhodes M.E. Sexually diergic hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine infusion, and nicotine withdrawal by mecamylamine in rats. Brain Res Bull 2011, 85:145-152.
45. Gibbs R.B. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev 2010, 31:224-253.
46. Girdler S.S., Jamner L.D., Jarvik M., Soles J.R., Shapiro D. Smoking status and nicotine administration differentially modify hemodynamic stress reactivity in men and women. Psychosom Med 1997, 59:294-306.
47. Glassman A.H., Helzer J.E., Covey L.S., Cottler L.B., Stetner F., Tipp J.E., et al. Smoking, smoking cessation, and major depression. JAMA 1990, 264:1546-1549.
48. Goel N., Bale T.L. Examining the intersection of sex and stress in modelling neuropsychiatric disorders. J Neuroendocrinol 2009, 21:415-420.
49. Goodwin G.M. Aromatase inhibitors and bipolar mood disorder: a case report. Bipolar Disord 2006, 8:516-518.
50. Gotteland M., Desauty G., Delarue J.C., Liu L., May E. Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues. Mol Cell Endocrinol 1995, 112:1-13.
51. Graziottin A., Serafini A. Depression and the menopause: why antidepressants are not enough?. Menopause Int 2009, 15:76-81.
52. Grigoriadis S., Robinson G.E. Gender issues in depression. Ann Clin Psychiatry 2007, 19:247-255.
53. Groer M.W., Morgan K. Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology 2007, 32:133-139.
54. Grossman M.P., Nakajima S.T. Menstrual cycle bleeding patterns in cigarette smokers. Contraception 2006, 73:562-565.
55. Guardiola-Diaz H.M., Boswell C., Seasholtz A.F. The cAMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. J Biol Chem 1994, 269:14,784-14,791.
56. Gundlah C., Pecins-Thompson M., Schutzer W.E., Bethea C.L. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Brain Res Mol Brain Res 1999, 63:325-339.
57. Gundlah C., Kohama S.G., Mirkes S.J., Garyfallou V.T., Urbanski H.F., Bethea C.L. Distribution of estrogen receptor beta (ERβ) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement. Brain Res Mol Brain Res 2000, 76:191-204.
58. Hileman S.M., Handa R.J., Jackson G.L. Distribution of estrogen receptor-β messenger ribonucleic acid in the male sheep hypothalamus. Biol Reprod 1999, 60:1279-1284.
59. Ho S.M., Leung Y.K., Chung I. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Ann N Y Acad Sci 2006, 1089:177-193.
60. Hobfoll S.E., Ritter C., Lavin J., Hulsizer M.R., Cameron R.P. Depression prevalence and incidence among inner-city pregnant and postpartum women. J Consult Clin Psychol 1995, 63:445-453.
61. Hori H., Ozeki Y., Teraishi T., Matsuo J., Kawamoto Y., Kinoshita Y., et al. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults. J Psychiatr Res 2010, 44:865-873.
62. Horvath L.G., Henshall S.M., Lee C.S., Head D.R., Quinn D.I., Makela S., et al. Frequent loss of estrogen receptor-β expression in prostate cancer. Cancer Res 2001, 61:5331-5335.
63. Hosli E., Ruhl W., Hosli L. Histochemical and electrophysiological evidence for estrogen receptors on cultured astrocytes: colocalization with cholinergic receptors. Int J Dev Neurosci 2000, 18:101-111.
64. Hosli E., Jurasin K., Ruhl W., Luthy R., Hosli L. Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system. Int J Dev Neurosci 2001, 19:11-19.
65. Hughes J.R. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 2007, 9:315-327.
66. Hughes Z.A., Liu F., Platt B.J., Dwyer J.M., Pulicicchio C.M., Zhang G., et al. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology 2008, 54:1136-1142.
67. Imwalle D.B., Gustafsson J.A., Rissman E.F. Lack of functional estrogen receptor β influences anxiety behavior and serotonin content in female mice. Physiol Behav 2005, 84:157-163.
68. Itoi K., Seasholtz A.F., Watson S.J. Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons. Endocr J 1998, 45:13-33.
69. Jakab R.L., Wong J.K., Belcher S.M. Estrogen receptor β immunoreactivity in differentiating cells of the developing rat cerebellum. J Comp Neurol 2001, 430:396-409.
70. Janowsky D.S., el-Yousef M.K., Davis J.M., Sekerke H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972, 2:632-635.
71. Janowsky D.S., el-Yousef M.K., Davis J.M. Acetylcholine and depression. Psychosom Med 1974, 36:248-257.
72. Jensen J., Christiansen C., Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985, 313:973-975.
73. Jin X., Steinbach J.H. A portable site: a binding element for 17β-estradiol can be placed on any subunit of a nicotinic α4β2 receptor. J Neurosci 2011, 31:5045-5054.
74. Jolley S.N., Elmore S., Barnard K.E., Carr D.B. Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression. Biol Res Nurs 2007, 8:210-222.
75. Kalman D., Morissette S.B., George T.P. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005, 14:106-123.
76. Kandi P., Hayslett R.L. Nicotine and 17β-estradiol produce an antidepressant-like effect in femal ovariectomized rats. Brain Res Bull 2011, 84:224-228.
77. Kelly M.J., Qiu J., Ronnekleiv O.K. Estrogen signaling in the hypothalamus. Vitam Horm 2005, 71:123-145.
78. Kendler K.S., Kessler R.C., Neale M.C., Heath A.C., Eaves L.J. The prediction of major depression in women: toward an integrated etiologic model. Am J Psychiatry 1993, 150:1139-1148.
79. Kim H.J., Casadesus G. Estrogen-mediated effects on cognition and synaptic plasticity: what do estrogen receptor knockout models tell us?. Biochim Biophys Acta 2010, 1800:1090-1093.
80. Konstantinopoulos P.A., Kominea A., Vandoros G., Sykiotis G.P., Andricopoulos P., Varakis I., et al. Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003, 39:1251-1258.
81. Koonce C.J., Walf A.A., Frye C.A. Trilostane exerts antidepressive effects among wild-type, but not estrogen receptor β knockout mice. Neuroreport 2009, 20:1047-1050.
82. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci U S A 1998, 95:15,677-15,682.
83. Krezel W., Dupont S., Krust A., Chambon P., Chapman P.F. Increased anxiety and synaptic plasticity in estrogen receptor β-deficient mice. Proc Natl Acad Sci U S A 2001, 98:12,278-12,282.
84. Kruijver F.P., Balesar R., Espila A.M., Unmehopa U.A., Swaab D.F. Estrogen-receptor-β distribution in the human hypothalamus: similarities and differences with ERα distribution. J Comp Neurol 2003, 466:251-277.
85. Kudwa A.E., Rissman E.F. Double oestrogen receptor α and β knockout mice reveal differences in neural oestrogen-mediated progestin receptor induction and female sexual behaviour. J Neuroendocrinol 2003, 15:978-983.
86. Kudwa A.E., Bodo C., Gustafsson J.A., Rissman E.F. A previously uncharacterized role for estrogen receptor β: defeminization of male brain and behavior. Proc Natl Acad Sci U S A 2005, 102:4608-4612.
87. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996, 93:5925-5930.
88. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997, 138:863-870.
89. Kuiper G.G., Shughrue P.J., Merchenthaler I., Gustafsson J.A. The estrogen receptor β subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol 1998, 19:253-286.
90. Laflamme N., Nappi R.E., Drolet G., Labrie C., Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol 1998, 36:357-378.
91. Lee S.J., McEwen B.S. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 2001, 41:569-591.
92. Leung Y.K., Mak P., Hassan S., Ho S.M. Estrogen receptor (ER)-β isoforms: a key to understanding ER-β signaling. Proc Natl Acad Sci U S A 2006, 103:13,162-13,167.
93. Leventhal L., Brandt M.R., Cummons T.A., Piesla M.J., Rogers K.E., Harris H.A. An estrogen receptor-β agonist is active in models of inflammatory and chemical-induced pain. Eur J Pharmacol 2006, 553:146-148.
94. Levin E.D., Rezvani A.H. Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol 2000, 393:141-146.
95. Lovejoy M.C., Graczyk P.A., O'Hare E., Neuman G. Maternal depression and parenting behavior: a meta-analytic review. Clin Psychol Rev 2000, 20:561-592.
96. Lund T.D., Rovis T., Chung W.C., Handa R.J. Novel actions of estrogen receptor-β on anxiety-related behaviors. Endocrinology 2005, 146:797-807.
97. Lund T.D., Hinds L.R., Handa R.J. The androgen 5α-dihydrotestosterone and its metabolite 5α-androstan-3β, 17β-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor β-expressing neurons in the hypothalamus. J Neurosci 2006, 26:1448-1456.
98. Masson C.L., Gilbert D.G. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers. J Behav Med 1999, 22:589-604.
99. Matta S.G., Fu Y., Valentine J.D., Sharp B.M. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998, 23:103-113.
100. McClernon F.J., Hiott F.B., Westman E.C., Rose J.E., Levin E.D. Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology (Berl) 2006, 189:125-133.
101. McGrire J.L., Lisk R.D. Localization of estrogen receptors in the rat hypothalamus. Neuroendocrinology 1969, 4:289-295.
102. McVay M.A., Copeland A.L. Smoking cessation in peri- and postmenopausal women: a review. Exp Clin Psychopharmacol 2011, 19:192-202.
103. Meinlschmidt G., Martin C., Neumann I.D., Heinrichs M. Maternal cortisol in late pregnancy and hypothalamic-pituitary-adrenal reactivity to psychosocial stress postpartum in women. Stress 2010, 13:163-171.
104. Melia K.R., Duman R.S. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci U S A 1991, 88:8382-8386.
105. Meltzer-Brody S., Stuebe A., Dole N., Savitz D., Rubinow D., Thorp J. Elevated corticotropin releasing hormone (CRH) during pregnancy and risk of postpartum depression (PPD). J Clin Endocrinol Metab 2011, 96:E40-E47.
106. Meziane H., Ouagazzal A.M., Aubert L., Wietrzych M., Krezel W. Estrous cycle effects on behavior of C57BL/6J and BALB/cByJ female mice: implications for phenotyping strategies. Genes Brain Behav 2007, 6:192-200.
107. Miller W.J., Suzuki S., Miller L.K., Handa R., Uht R.M. Estrogen receptor (ER)β isoforms rather than ERα regulate corticotropin-releasing hormone promoter activity through an alternate pathway. J Neurosci 2004, 24:10,628-10,635.
108. Mineur Y.S., Picciotto M.R. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci 2010, 31:580-586.
109. Mitra S.W., Hoskin E., Yudkovitz J., Pear L., Wilkinson H.A., Hayashi S., et al. Immunolocalization of estrogen receptor β in the mouse brain: comparison with estrogen receptor α. Endocrinology 2003, 144:2055-2067.
110. Moore J.T., McKee D.D., Slentz-Kesler K., Moore L.B., Jones S.A., Horne E.L., et al. Cloning and characterization of human estrogen receptor β isoforms. Biochem Biophys Res Commun 1998, 247:75-78.
111. Mosselman S., Polman J., Dijkema R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996, 392:49-53.
112. Mueck A.O., Seeger H. Smoking, estradiol metabolism and hormone replacement therapy. Curr Med Chem Cardiovasc Hematol Agents 2005, 3:45-54.
113. Naert G., Maurice T., Tapia-Arancibia L., Givalois L. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats. Psychoneuroendocrinology 2007, 32:1062-1078.
114. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1996, 1:336-342.
115. Nemeroff C.B. Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Neuron 2008, 59:185-186.
116. Ogawa S., Inoue S., Watanabe T., Hiroi H., Orimo A., Hosoi T., et al. The complete primary structure of human estrogen receptor β (hERβ) and its heterodimerization with ER α in vivo and in vitro. Biochem Biophys Res Commun 1998, 243:122-126.
117. Ogawa S., Chan J., Chester A.E., Gustafsson J.A., Korach K.S., Pfaff D.W. Survival of reproductive behaviors in estrogen receptor β gene-deficient (βERKO) male and female mice. Proc Natl Acad Sci U S A 1999, 96:12,887-12,892.
118. Ogawa S., Chan J., Gustafsson J.A., Korach K.S., Pfaff D.W. Estrogen increases locomotor activity in mice through estrogen receptor α: specificity for the type of activity. Endocrinology 2003, 144:230-239.
119. O'Hara M.W. Postpartum depression: what we know. J Clin Psychol 2009, 65:1258-1269.
120. Okuda H., Shioda S., Nakai Y., Nakayama H., Okamoto M., Nakashima T. Immunocytochemical localization of nicotinic acetylcholine receptor in rat hypothalamus. Brain Res 1993, 625:145-151.
121. Okuda H., Shioda S., Nakai Y., Nakayama H., Okamoto M., Nakashima T. The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat. Neurosci Lett 1993, 161:183-186.
122. Osler M., Prescott E., Godtfredsen N., Hein H.O., Schnohr P. Gender and determinants of smoking cessation: a longitudinal study. Prev Med 1999, 29:57-62.
123. Osterlund M.K., Halldin C., Hurd Y.L. Effects of chronic 17β-estradiol treatment on the serotonin 5-HT1A receptor mRNA and binding levels in the rat brain. Synapse 2000, 35:39-44.
124. Paulmyer-Lacroix O., Hery M., Pugeat M., Grino M. The modulatory role of estrogens on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of ovariectomized rats: role of the adrenal gland. J Neuroendocrinol 1996, 8:515-519.
125. Philip N.S., Carpenter L.L., Tyrka A.R., Price L.H. Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl) 2010, 212:1-12.
126. Philip N.S., Carpenter L.L., Tyrka A.R., Price L.H. The nicotinic acetylcholine receptor as a target for antidepressant drug development. ScientificWorldJournal 2012, 2012:104105.
127. Picciotto M.R., Addy N.A., Mineur Y.S., Brunzell D.H. It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 2008, 84:329-342.
128. Pike C.J., Carroll J.C., Rosario E.R., Barron A.M. Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 2009, 30:239-258.
129. Pogun S. Sex differences in brain and behavior: emphasis on nicotine, nitric oxide and place learning. Int J Psychophysiol 2001, 42:195-208.
130. Poola I., Abraham J., Baldwin K., Saunders A., Bhatnagar R. Estrogen receptors beta4 and beta5 are full length functionally distinct ERβ isoforms: cloning from human ovary and functional characterization. Endocrine 2005, 27:227-238.
131. Raval A.P., Bhatt A., Saul I. Chronic nicotine exposure inhibits 17β-estradiol-mediated protection of the hippocampal CA1 region against cerebral ischemia in female rats. Neurosci Lett 2009, 458:65-69.
132. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
133. Reul J.M., van den Bosch F.R., de Kloet E.R. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol 1987, 115:459-467.
134. Rocha B.A., Fleischer R., Schaeffer J.M., Rohrer S.P., Hickey G.J. 17β-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-β knockout (BERKO) mice. Psychopharmacology (Berl) 2005, 179:637-643.
135. Salin-Pascual R.J. Relationship between mood improvement and sleep changes with acute nicotine administration in non-smoking major depressed patients. Rev Invest Clin 2002, 54:36-40.
136. Saricicek A., Esterlis I., Maloney K.H., Mineur Y.S., Ruf B.M., Muralidharan A., et al. Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry 2012, 169:851-859.
137. Schneider T., Popik P. Increased depressive-like traits in an animal model of premenstrual irritability. Horm Behav 2007, 51:142-148.
138. Sharp B.M., Nicol S., Cummings S., Seybold V. Distribution of nicotinic binding sites with respect to CRF and neurophysin immunoreactive perikarya within the rat hypothalamus. Brain Res 1987, 422:361-366.
139. Shea A., Walsh C., Macmillan H., Steiner M. Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females. Psychoneuroendocrinology 2005, 30:162-178.
140. Sheng Z., Yanai A., Fujinaga R., Kawano J., Tanaka M., Watanabe Y., et al. Gonadal and adrenal effects on the glucocorticoid receptor in the rat hippocampus, with special reference to regulation by estrogen from an immunohistochemical view-point. Neurosci Res 2003, 46:205-218.
141. Shingo A.S., Yonezawa M., Sakurai K., Kito S. Nicotine inhibits estrogen response element binding in the rat brain. J Neural Transm 2000, 107:1491-1495.
142. Shughrue P.J., Komm B., Merchenthaler I. The distribution of estrogen receptor-β mRNA in the rat hypothalamus. Steroids 1996, 61:678-681.
143. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J Comp Neurol 1997, 388:507-525.
144. Solomon M.B., Herman J.P. Sex differences in psychopathology: of gonads, adrenals and mental illness. Physiol Behav 2009, 97:250-258.
145. Steiner M., Dunn E., Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord 2003, 74:67-83.
146. Steiner R.C., Heath C.J., Picciotto M.R. Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII. J Neurochem 2007, 103:666-678.
147. Suzuki S., Handa R.J. Regulation of estrogen receptor-β expression in the female rat hypothalamus: differential effects of dexamethasone and estradiol. Endocrinology 2004, 145:3658-3670.
148. Swaab D.F. Neuropeptides in hypothalamic neuronal disorders. Int Rev Cytol 2004, 240:305-375.
149. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005, 4:141-194.
150. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
151. Tang K., Wu H., Mahata S.K., O'Connor D.T. A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells. Mol Pharmacol 1998, 54:59-69.
152. Thompson D.S., Spanier C.A., Vogel V.G. The relationship between tamoxifen, estrogen, and depressive symptoms. Breast J 1999, 5:375-382.
153. Tong V.T., Jones J.R., Dietz P.M., D'Angelo D., Bombard J.M. Trends in smoking before, during, and after pregnancy - Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. MMWR Surveill Summ 2009, 58:1-29.
154. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002, 53:865-871.
155. Vamvakopoulos N.C., Chrousos G.P. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J Clin Invest 1993, 92:1896-1902.
156. van de Stolpe A., Slycke A.J., Reinders M.O., Zomer A.W., Goodenough S., Behl C., et al. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta. Mol Endocrinol 2004, 18:2908-2923.
157. Walf A.A., Frye C.A. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 2007, 86:407-414.
158. Walf A.A., Rhodes M.E., Frye C.A. Antidepressant effects of ERβ-selective estrogen receptor modulators in the forced swim test. Pharmacol Biochem Behav 2004, 78:523-529.
159. Walf A.A., Koonce C.J., Frye C.A. Adult female wildtype, but not oestrogen receptor β knockout, mice have decreased depression-like behaviour during pro-oestrus and following administration of oestradiol or diarylpropionitrile. J Psychopharmacol 2009, 23:442-450.
160. Wang L., Andersson S., Warner M., Gustafsson J.A. Morphological abnormalities in the brains of estrogen receptor β knockout mice. Proc Natl Acad Sci U S A 2001, 98:2792-2796.
161. Wang L., Andersson S., Warner M., Gustafsson J.A. Estrogen receptor (ER)β knockout mice reveal a role for ERβ in migration of cortical neurons in the developing brain. Proc Natl Acad Sci U S A 2003, 100:703-708.
162. Weiser M.J., Foradori C.D., Handa R.J. Estrogen receptor beta in the brain: from form to function. Brain Res Rev 2008, 57:309-320.
163. Weiser M.J., Wu T.J., Handa R.J. Estrogen receptor-β agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress. Endocrinology 2009, 150:1817-1825.
164. Weiser M.J., Foradori C.D., Handa R.J. Estrogen receptor beta activation prevents glucocorticoid receptor-dependent effects of the central nucleus of the amygdala on behavior and neuroendocrine function. Brain Res 2010, 1336:78-88.
165. Wisner K.L., Parry B.L., Piontek C.M. Clinical practice. Postpartum depression. N Engl J Med 2002, 347:194-199.
166. Yang N.N., Venugopalan M., Hardikar S., Glasebrook A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 1996, 273:1222-1225.
167. Yu G., Sharp B.M. Nicotine self-administration diminishes stress-induced norepinephrine secretion but augments adrenergic-responsiveness in the hypothalamic paraventricular nucleus and enhances adrenocorticotropic hormone and corticosterone release. J Neurochem 2010, 112:1327-1337.
168. Yu G., Sharp B.M. Nicotine modulates multiple regions in the limbic stress network regulating activation of hypophysiotrophic neurons in hypothalamic paraventricular nucleus. J Neurochem 2012, 122:628-640.
169. Zhao L., Wu T.W., Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res 2004, 1010:22-34.
170. Zhao C., Matthews J., Tujague M., Wan J., Strom A., Toresson G., et al. Estrogen receptor β2 negatively regulates the transactivation of estrogen receptor α in human breast cancer cells. Cancer Res 2007, 67:3955-3962.